Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Yiyue, Xu"'
Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The advent of immunotherapy has greatly improved the prognosis of non-small cell lung (NSCLC) patients. However, given its low response rate and high cost of treatment, the search for valuable predictive markers of treatment efficacy is nece
Externí odkaz:
https://doaj.org/article/abb5f383265d4a5cab9c2abb38609dca
Publikováno v:
Energies, Vol 17, Iss 20, p 5019 (2024)
Due to real-time fluctuations in wind farm output, large-scale renewable energy (RE) generation poses significant challenges to power system stability. To address this issue, this paper proposes a deep reinforcement learning (DRL)-based electric hydr
Externí odkaz:
https://doaj.org/article/ae352ed37dd54fe891eedbda6c9bf929
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Background Immune checkpoint inhibitors (ICIs) combined with chemotherapy have been recommended as the standard treatment for advanced NSCLC patients without driver‐gene mutations. However, there are different genetic characteristics and b
Externí odkaz:
https://doaj.org/article/c230b22d104046c990612f4e89f715c8
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Cancer treatment is gradually entering an era of precision, with multitude studies in gene testing and immunotherapy. Tumor cells can be recognized and eliminated by the immune system through the expression of tumor-associated antigens, but
Externí odkaz:
https://doaj.org/article/22500c10cf4145038cd0565f9c904c99
Autor:
Linlin Yang, Xinyu Fan, Wenru Qin, Yiyue Xu, Bing Zou, Bingjie Fan, Shijiang Wang, Taotao Dong, Linlin Wang
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4246-4255 (2022)
Abstract Background Accurate prognostic prediction plays a crucial role in the clinical setting. However, the TNM staging system fails to provide satisfactory individual survival prediction for stage III non‐small cell lung cancer (NSCLC). The perf
Externí odkaz:
https://doaj.org/article/b3782c610f1e4fbfbf415fbbff114623
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background The efficacy of bevacizumab in non-small cell lung cancer (NSCLC) patients is unsatisfactory, and the selection of suitable patients is still challenging. Given the epigenetic modifications can contribute to an aberrant regulation
Externí odkaz:
https://doaj.org/article/074b7dcd2a3c45b9a2299e36fdde48fa
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6291-6303 (2021)
Background Many tools have been developed to predict the efficacy of immunotherapy, such as lung immune prognostic index (LIPI), EPSILoN [Eastern Cooperative Oncology Group performance status (ECOG PS), smoking, liver metastases, lactate dehydrogenas
Externí odkaz:
https://doaj.org/article/15a920c0d6c44045b8ded1c665748f46
Autor:
Yiyue Xu, Hui Cui, Taotao Dong, Bing Zou, Bingjie Fan, Wanlong Li, Shijiang Wang, Xindong Sun, Jinming Yu, Linlin Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Background and PurposeThis study aims to develop a risk model to predict esophageal fistula in esophageal cancer (EC) patients by learning from both clinical data and computerized tomography (CT) radiomic features.Materials and MethodsIn this retrosp
Externí odkaz:
https://doaj.org/article/fcf5aba1cfac43928a6f6bcb67f44353
Autor:
Yiyue Xu, Linlin Wang, Bo He, Wanlong Li, Qiang Wen, Shijiang Wang, Xindong Sun, Xue Meng, Jinming Yu
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-8 (2019)
Abstract Objectives We aimed to identify the risk factors and provide a nomogram for the prediction of radiotherapy-related esophageal fistula in patients with esophageal cancer (EC) using a case-control study. Patients and methods Patients with esop
Externí odkaz:
https://doaj.org/article/3511ab1196c4402e9a4ea1cebf44f1a3
Autor:
Meiying Guo, Butuo Li, Yishan Yu, Shijiang Wang, Yiyue Xu, Xindong Sun, Linlin Wang, Jinming Yu
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 2587-2598 (2019)
Abstract Introduction Locally advanced nonsmall‐cell lung cancer (LA‐NSCLC) represented a highly heterogeneous group, with more than half of the patients aged ≥65 years at the time of diagnosis. However, the optimal treatment for elderly LA‐N
Externí odkaz:
https://doaj.org/article/db231984acf6440cbde10edd47e76937